维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Castleberry RP"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors显示文摘	Emanuel PD Bates LJ Castleberry RP	1991	Blood1991，77，5：	1
2	The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease显示文摘	Kratz CP Niemeyer CM Castleberry RP	2005	Blood2005，106，6：	1
3	Genetic staging of unresectable or metastatic neuroblastoma in infants:a Pediatric Oncology Group study显示文摘	Bowman LC Castleberry RP Cantor A		0，，5：	1
4	Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemo- therapy: a Pediatric Oncology Group study显示文摘	Castleberry RP Shuster J J Ahshuler G	1992	J Clin On- col1992，10，8：	1
5	Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratiication in the Children's Oncology Group 显示文摘	London WB Castleberry RP Matthay KK	2005	J Clin 0ncol2005，23，27：	1
6	International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma显示文摘	Brodeur GM Seeger RC Barrett A Berthold F Castleberry RP D′Angio G	1988	J Clin Oncol1988，6，12：	1
7	International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma 显示文摘	Brodeur GM Seeger RC Barrett A Berthold F Castleberry RP D' Angio G	1988	J Clin Oncol1988，6，12：	1
8	Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children′s Oncology Group显示文摘	London WB Castleberry RP Matthay KK		0，，27：	1
9	Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oneology Group显示文摘	London WB1 Castleberry RP Matthay KK	2005	JClin Oncol2005，23，27：	1
10	Accidental poisoning with a superwarfarin compound (brodifacoum) in a child显示文摘	Watts RG Castleberry RP Sadowski JA	1990	Pediatrics1990，86，：	1
11	Juvenile chronic myelogenous leukemia显示文摘	Hess JL Zutter MM Castleberry RP	1996	Am J Clin Pathol1996，105，：	1
12	International criteria for diagnosis,staging,and response to treatment in patients with neuroblastoma显示文摘	Brodeur GM Seeger RC Barrett A Berthold F Castleberry RP D'Angio G	1988	J Clin Oncol1988，6，12：	1
13	Genetic Staging of Unresectable or Metastatic Neuroblastomain Infants: a Pediatric Oncology Group Study显示文摘	Bowman LC Castleberry RP Cantor A	1997	J Natl Cancer Inst1997，89，5：	1
14	Evidence for an ageeut-off greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group显示文摘	London WB Castleberry RP Matthay KK		0，，27：	1
15	PTEN deficiency is a common de fect in juvenile myelomonocytic leukemia显示文摘	Liu YL Castleberry RP Emanuel PD	2009	Leuk Res2009，33，5：	1
16	Consistently investigating the inconsistent nature of neuroblastoma显示文摘	Castleberry RP		0，，03：	1
17	PTEN deficiency is a common de- fect in juvenile myelomonocytic leukemia 显示文摘	Liu YL Castleberry RP Emanuel PD	2009	Leuk Res2009，33，5：	1
18	Neuroblastoma 显示文摘	Castleberry RP	1997	Eur J Cancer1997，33，9：	1
19	PTEN deficiency is a common defect in juvenile myelomonocytic leukemia显示文摘	Liu YL Castleberry RP Emanuel PD	2009	Leuk Res2009，33，5：	1
20	Decitabine,a potential targeted therapeutic for juvenile myelomonocytic leukemia显示文摘	Liu YL Emeanuel PD Castleberry RP	2005	Blood2005，106，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示